Issue 1/2013
Content (25 Articles)
How relevant is hormone receptor status in the context of outcome to HER2-positive breast cancer?
Nadine Norton, Edith A Perez
BMP/Coco antagonism as a deterministic factor of metastasis dormancy in lung
Jarrod Martinez, Xiang H-F Zhang
Visualizing movement in the tumor microenvironment landscape
Veronica Calvo, Paraic A Kenny
Patient-derived breast tumor xenografts facilitating personalized cancer therapy
Melissa D Landis, Brian D Lehmann, Jennifer A Pietenpol, Jenny C Chang
Hypoxia stimulates migration of breast cancer cells via the PERK/ATF4/LAMP3-arm of the unfolded protein response
Anika Nagelkerke, Johan Bussink, Hilda Mujcic, Bradly G Wouters, Steffi Lehmann, Fred CGJ Sweep, Paul N Span
Comparison of percent density from raw and processed full-field digital mammography data
Celine M Vachon, Erin EE Fowler, Gail Tiffenberg, Christopher G Scott, V Shane Pankratz, Thomas A Sellers, John J Heine
Elafin, an inhibitor of elastase, is a prognostic indicator in breast cancer
Kelly K Hunt, Hannah Wingate, Tomoya Yokota, Yanna Liu, Gordon B Mills, Fan Zhang, Bingliang Fang, Chun-Hui Su, Ming Zhang, Min Yi, Khandan Keyomarsi
Promoter hypermethylation of the tumor-suppressor genes ITIH5, DKK3, and RASSF1A as novel biomarkers for blood-based breast cancer screening
Vera Kloten, Birte Becker, Kirsten Winner, Michael G Schrauder, Peter A Fasching, Tobias Anzeneder, Jürgen Veeck, Arndt Hartmann, Ruth Knüchel, Edgar Dahl
The prognostic significance and value of cyclin D1, CDK4 and p16 in human breast cancer
Emmi Peurala, Peppi Koivunen, Kirsi-Maria Haapasaari, Risto Bloigu, Arja Jukkola-Vuorinen
RhoB modifies estrogen responses in breast cancer cells by influencing expression of the estrogen receptor
Claire Médale-Giamarchi, Isabelle Lajoie-Mazenc, Emilie Malissein, Elise Meunier, Bettina Couderc, Yann Bergé, Thomas Filleron, Laura Keller, Claudine Marty, Magali Lacroix-Triki, Florence Dalenc, Sophie F Doisneau-Sixou, Gilles Favre
Mammographic density as a predictor of breast cancer survival: the Multiethnic Cohort
Gertraud Maskarinec, Ian S Pagano, Melissa A Little, Shannon M Conroy, Song-Yi Park, Laurence N Kolonel
Combinatorial targeting of FGF and ErbB receptors blocks growth and metastatic spread of breast cancer models
Amine Issa, Jason W Gill, Marinus R Heideman, Ozgur Sahin, Stefan Wiemann, Julien H Dey, Nancy E Hynes
A functional link between FOXA1 and breast cancer SNPs
Madhumohan R Katika, Antoni Hurtado
Tissue transglutaminase as a central mediator in inflammation-induced progression of breast cancer
Navneet Agnihotri, Santosh Kumar, Kapil Mehta
Contralateral breast cancer risk in BRCA1/2-positive families needs to be adjusted for phenocopy rates particularly in second-degree untested relatives
D Gareth R Evans, Anthony Howell, Sarah L Ingham, Iain Buchan
Hormone-sensing cells require Wip1 for paracrine stimulation in normal and premalignant mammary epithelium
Gerard A Tarulli, Duvini De Silva, Victor Ho, Kamini Kunasegaran, Kakaly Ghosh, Bryan C Tan, Dmitry V Bulavin, Alexandra M Pietersen
Mammographic density and risk of breast cancer according to tumor characteristics and mode of detection: a Spanish population-based case-control study
Marina Pollán, Nieves Ascunce, María Ederra, Alberto Murillo, Nieves Erdozáin, Jose Enrique Alés-Martínez, Roberto Pastor-Barriuso
HER2 and ESR1 mRNA expression levels and response to neoadjuvant trastuzumab plus chemotherapy in patients with primary breast cancer
Carsten Denkert, Jens Huober, Sibylle Loibl, Judith Prinzler, Ralf Kronenwett, Silvia Darb-Esfahani, Jan C Brase, Christine Solbach, Keyur Mehta, Peter A Fasching, Bruno V Sinn, Knut Engels, Mattea Reinisch, Martin-Leo Hansmann, Hans Tesch, Gunter von Minckwitz, Michael Untch
Anti-matrix metalloproteinase-9 DNAzyme decreases tumor growth in the MMTV-PyMT mouse model of breast cancer
Miranda A Hallett, Bin Teng, Hisashi Hasegawa, Luciana P Schwab, Tiffany N Seagroves, Tayebeh Pourmotabbed
Optical imaging correlates with magnetic resonance imaging breast density and revealscomposition changes during neoadjuvant chemotherapy
Thomas D O'Sullivan, Anaïs Leproux, Jeon-Hor Chen, Shadfar Bahri, Alex Matlock, Darren Roblyer, Christine E McLaren, Wen-Pin Chen, Albert E Cerussi, Min-Ying Su, Bruce J Tromberg
Circulating levels of 25-hydroxyvitamin D and risk of breast cancer: a nested case-control study
Stephanie Scarmo, Yelena Afanasyeva, Per Lenner, Karen L Koenig, Ronald L Horst, Tess V Clendenen, Alan A Arslan, Yu Chen, Göran Hallmans, Eva Lundin, Sabina Rinaldi, Paolo Toniolo, Roy E Shore, Anne Zeleniuch-Jacquotte
Metabolic biomarkers for response to PI3K inhibition in basal-like breast cancer
Siver A Moestue, Cornelia G Dam, Saurabh S Gorad, Alexandr Kristian, Anna Bofin, Gunhild M Mælandsmo, Olav Engebråten, Ingrid S Gribbestad, Geir Bjørkøy
Prevalence of PALB2 mutations in Australasian multiple-case breast cancer families
Zhi L Teo, Daniel J Park, Elena Provenzano, Catherine A Chatfield, Fabrice A Odefrey, Tu Nguyen-Dumont, James G Dowty, John L Hopper, Ingrid Winship, David E Goldgar, Melissa C Southey
Breast cancer in women using digoxin: tumor characteristics and relapse risk
Robert J Biggar, Elisabeth W Andersen, Niels Kroman, Jan Wohlfahrt, Mads Melbye